Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Westminster Securities Corp. was a New York-based investment bank and broker-dealer that specialized in the life sciences and technology sectors. The firm was a prominent player in the micro-cap and small-cap markets, particularly known for its Life Sciences Group, which facilitated numerous Private Investment in Public Equity (PIPE) transactions for emerging biotechnology companies. Beyond investment banking, Westminster provided institutional sales, trading, and equity research services tailored to the healthcare industry. The company served as a key financial intermediary, helping to fund early-stage drug development and medical technology firms. In 2007, Westminster Securities was acquired by Hudson Holding Corp. to bolster its institutional healthcare capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Westminster Securities.